Latest Period
Q2 2026
CUSIP: 70387R502
Latest Period
Q2 2026
Institutions Reporting
18
Shares (Excl. Options)
935,854
Price
$5.94
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 18 institutions filings for Q2 2026.
Security key
70387R502
Latest holder period
Q2 2026
13F holders
18
13D/G owners
1
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 70387R502:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| NAGELBERG DAVID S | 8.8% | $4,156,681 | 699,778 | NAGELBERG DAVID S | 30 Jun 2026 |
As of 30 Jun 2026, 18 institutional investors reported holding 935,854 shares of PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM). This represents 12% of the company’s total 7,952,023 outstanding shares.
13F concentration
Largest 13F positions for this security by reported shares and value.
Quarter history
Holder count, reported shares/value, and median price by quarter.